packageAdagrasib

adagrasib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Adagrasib is an anticancer medicine used to treat non-small-cell lung cancer. It is an approved antineoplastic agent and is authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q105816120 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:adagrasib
ATC codes:L01XX77
DrugBank:DB15568
PubChem CID:138611145
Wikidata:Q105816120
formula:C32H35ClFN7O2
molar mass:604.127 g/mol (PubChem CID 138611145)
logP:5 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown